Sertoli-Leydig cell tumour (SLCT) – the case of a 15 cm diameter ovarian tumour with negative markers and absent hormonal symptoms

Michał Ciebiera; Arkadiusz Baran; Aneta Słabuszewska-Jóźwiak; Cezary Wojtyła; Grzegorz Jakiel

doi:10.5114/jhi.2019.87847

eISSN: 2450-5722
ISSN: 2450-5927

Journal of Health Inequalities

Current issue Archive Online first About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2019
vol. 5

Send email

Copy url:

abstract:

Case report

Sertoli-Leydig cell tumour (SLCT) – the case of a 15 cm diameter ovarian tumour with negative markers and absent hormonal symptoms

Michał Ciebiera

¹

,

Arkadiusz Baran

²

,

Aneta Słabuszewska-Jóźwiak

²

,

Cezary Wojtyła

³

,

Grzegorz Jakiel

²

Second Department of Obstetrics and Gynaecology, The Centre of Postgraduate Medical Education, Warsaw, Poland
First Department of Obstetrics and Gynaecology, The Centre of Postgraduate Medical Education, Warsaw, Poland
European Observatory of Health Inequalities, the President Stanisław Wojciechowski State University of Applied Sciences in Kalisz, Poland

J Health Inequal 2019; 5 (1): 117-119

DOI: https://doi.org/10.5114/jhi.2019.87847

Online publish date: 2019/07/31

View full text Get citation

PlumX metrics:

Sex cord-stromal tumours are a group of tumours derived from the stromal component of the ovary and testis that comprise granulosa, thecal, Sertoli, and Leydig cells as well as fibrocytes. Sertoli-Leydig cell tumours (SLCTs) are rare ovarian neoplasms, accounting for less than 1% of all cancers arising from this organ. They differ in size; some might be very small, while some of them are huge (from < 1 cm to 35 cm). Most SLCTs are unilateral and may be functionally diverse. Approximately one-fifth of SLCTs may contain various heterologous elements, e.g. gastric or intestinal-like epithelium or malignant parts. Women with SLCTs may suffer from hormonal disturbances, manifest high alpha-fetoprotein, CA125, and testosterone levels and may suffer from virilisation, oligomenorrhoea, hirsutism, acne, voice changes, clitoris hypertrophy, or alopecia. However, those symptoms do not occur in every case.

Diagnosis of SLCTs is not easy, due to its rarity and varied presentation. Even though SLCTs are rare tumours, they should always be considered as a possibility, even in patients at different ages (typically 20-30 years old) without raised markers and hormonal disturbances.

In this manuscript we report a case of SLCT, 15 cm in diameter, with low marker levels and lacking hormonal disturbances, found in a 36-year-old female.

keywords:

Sertoli-Leydig cell tumour, sex-cord stromal tumour, tumour marker, ovary, ovarian neoplasm, ultrasound

Journal published under the patronage of:

Sertoli-Leydig cell tumour (SLCT) – the case of a 15 cm diameter ovarian tumour with negative markers and absent hormonal symptoms

Michał Ciebiera 1 , Arkadiusz Baran 2 , Aneta Słabuszewska-Jóźwiak 2 , Cezary Wojtyła 3 , Grzegorz Jakiel 2

Sertoli-Leydig cell tumour, sex-cord stromal tumour, tumour marker, ovary, ovarian neoplasm, ultrasound

Michał Ciebiera

¹

,

Arkadiusz Baran

²

,

Aneta Słabuszewska-Jóźwiak

²

,

Cezary Wojtyła

³

,

Grzegorz Jakiel

²